T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Sportsman's Warehouse
SPWH
$47.6M
| $22.9M | ﹤0.01% |
3,134,610
+241,780
| +8% | +$1.74M |
|
1077
Harmonic Inc
HLIT
$1.43B
| $22.9M | ﹤0.01% |
3,271,883
+740,270
| +29% | +$4.94M |
|
1078
NewMarket
NEU
$8.64B
| $22.8M | ﹤0.01% |
56,600
-400
| -0.7% | -$154K |
|
|
CDR
1079
DELISTED
Cedar Realty Trust, Inc
CDR
| $22.8M | ﹤0.01% |
470,697
-7,818
| -2% | -$344K |
|
1080
Golub Capital BDC
GBDC
$3.48B
| $22.4M | ﹤0.01% |
1,276,403
-31,957
| -2% | -$538K |
|
|
IPG
1081
DELISTED
Interpublic Group of Companies
IPG
| $22.4M | ﹤0.01% |
1,078,519
-2,700
| -0.2% | -$51.9K |
|
|
ESIO
1082
DELISTED
Electro Scientific Industries
ESIO
| $22.4M | ﹤0.01% |
2,882,160
-34,100
| -1% | -$243K |
|
1083
Crocs
CROX
$6.31B
| $22.3M | ﹤0.01% |
1,784,520
+284,860
| +19% | +$3.52M |
|
1084
KeyCorp
KEY
$24.7B
| $22M | ﹤0.01% |
1,579,907
-26,000
| -2% | -$346K |
|
|
DDC
1085
DELISTED
Dominion Diamond Corporation
DDC
| $22M | ﹤0.01% |
1,218,640
+53,075
| +5% | +$823K |
|
|
PHX
1086
DELISTED
PHX Minerals
PHX
| $21.9M | ﹤0.01% |
940,270
+6,100
| +0.7% | +$129K |
|
|
TPH
1087
DELISTED
Tri Pointe Homes
TPH
| $21.7M | ﹤0.01% |
1,421,980
+1,262,480
| +792% | +$18M |
|
|
ULTI
1088
DELISTED
Ultimate Software Group Inc
ULTI
| $21.6M | ﹤0.01% |
147,297
-165,390
| -53% | -$24M |
|
|
EIGR
1089
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $21.6M | ﹤0.01% |
2,454
+217
| +10% | +$1.26M |
|
|
ISIL
1090
DELISTED
Intersil Corp
ISIL
| $21.5M | ﹤0.01% |
1,487,412
+1,045,460
| +237% | +$13.9M |
|
1091
ON Semiconductor
ON
$32.2B
| $21.4M | ﹤0.01% |
2,108,339
-2,089,300
| -50% | -$18.3M |
|
1092
Sally Beauty Holdings
SBH
$1.56B
| $21.4M | ﹤0.01% |
694,583
+23,183
| +3% | +$689K |
|
|
CRR
1093
DELISTED
Carbo Ceramics Inc.
CRR
| $21.3M | ﹤0.01% |
531,795
-243,650
| -31% | -$11.4M |
|
1094
Church & Dwight Co
CHD
$24B
| $21.1M | ﹤0.01% |
535,096
-8,956
| -2% | -$331K |
|
1095
NetApp
NTAP
$40.3B
| $21M | ﹤0.01% |
505,632
-520
| -0.1% | -$21.6K |
|
1096
Cohu
COHU
$2.8B
| $20.9M | ﹤0.01% |
1,755,250
-3,500
| -0.2% | -$39.8K |
|
1097
Avis
CAR
$4.95B
| $20.8M | ﹤0.01% |
313,800
-11,000
| -3% | -$629K |
|
|
LXFT
1098
DELISTED
Luxoft Holding, Inc.
LXFT
| $20.6M | ﹤0.01% |
534,232
+1,165
| +0.2% | +$44.1K |
|
1099
WEC Energy
WEC
$35.9B
| $20.5M | ﹤0.01% |
389,580
+2,410
| +0.6% | +$118K |
|
1100
BorgWarner
BWA
$13.9B
| $20.5M | ﹤0.01% |
424,432
+227
| +0.1% | +$11.1K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.